Pathophysiology and Advanced Treatment of Hematological Malignancy
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: 30 November 2024 | Viewed by 58
Special Issue Editor
Interests: molecular pathology; neuro-oncology; hematopathology; molecular diagnosis in oncology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Hematological malignancies represent an intricate addition to the oncological landscape, especially in light of the new classifications that have been characterized in recent years. An understanding of hematological malignancies is crucial, as well as delving into their underlying pathophysiology and the latest therapeutic breakthroughs in treating oncohematological neoplasms.
Nowadays, it is important to fully dive into the mechanisms driving hematological malignancies, such as genetic mutations and the subsequent dysregulation of various signal pathways, providing a feasible means of gaining insight into the risks of disease progression.
The role of the latest diagnostic tools and techniques is essential to improve the detection and classification of hematological malignancies, offering hope for early intervention and personalized treatment strategies.
Additionally, it is crucial to explore the landscape of novel therapeutic approaches, including targeted therapies (such as tyrosine-kinase inhibitors), immunotherapies, and gene editing techniques, highlighting promising perspectives for patient outcomes.
The aim of this Special Issue is to uncover the emerging trends and reviews shaping the future of hematological malignancy treatment, from precision medicine to innovative combination therapies. Since IJMS is a journal of molecular science, pure clinical or model studies will not be suitable for our journal. However, clinical or pure model submissions with biomolecular experiments are welcome.
Prof. Dr. Luigi Maria Larocca
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hematological malignancies
- lymphomas
- multiple myeloma
- bone marrow
- tyrosine-kinase inhibitors
- -novel therapies
- target therapy
